Highlights
When results are so encouraging, the path is traced: one step at a time towards the cure ~ Hemera’s Team
Hemera releases a quarterly update on its main activities marking the progress of the development and validation of REMAST therapy for the treatment of severe spinal cord injury.
The documents available in this section cannot include the many actions needed to bring Hemera to its goal as soon as possible, but they outline the exciting path towards the goal.
Hemera Year 2024
![](https://hemerapharma.com/wp-content/uploads/2022/11/Hemera_icone_1-trimestre.png)
1st Quarter
![](https://hemerapharma.com/wp-content/uploads/2022/11/Hemera_icone_2-trimestre.png)
2nd Quarter
![](https://hemerapharma.com/wp-content/uploads/2022/11/Hemera_icone_3-trimestre.png)
3rd Quarter
![](https://hemerapharma.com/wp-content/uploads/2022/11/Hemera_icone_4-trimestre.png)
4th Quarter
Hemera Year 2023
![](https://hemerapharma.com/wp-content/uploads/2022/11/Hemera_icone_1-trimestre.png)
1st Quarter
![](https://hemerapharma.com/wp-content/uploads/2022/11/Hemera_icone_2-trimestre.png)
2nd Quarter
![](https://hemerapharma.com/wp-content/uploads/2022/11/Hemera_icone_3-trimestre.png)
3rd Quarter
![](https://hemerapharma.com/wp-content/uploads/2022/11/Hemera_icone_4-trimestre.png)
4th Quarter
Hemera Year 2022
![](https://hemerapharma.com/wp-content/uploads/2022/11/Hemera_icone_1-trimestre.png)
1st Quarter
![](https://hemerapharma.com/wp-content/uploads/2022/11/Hemera_icone_2-trimestre.png)
2nd Quarter
![](https://hemerapharma.com/wp-content/uploads/2022/11/Hemera_icone_3-trimestre.png)
3rd Quarter
![](https://hemerapharma.com/wp-content/uploads/2022/11/Hemera_icone_4-trimestre.png)
4th Quarter
Hemera Year 2021
![](https://hemerapharma.com/wp-content/uploads/2022/12/hemera-icona-report-annuale.png)
Report 2021
Stay informed on Hemera’s latest activities with our Newsletter.